Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan;38(1):61-68.
doi: 10.1007/s11011-022-01082-6. Epub 2022 Sep 23.

Treatments against Polymorphosal discrepancies in Glioblastoma Multiforme

Affiliations
Review

Treatments against Polymorphosal discrepancies in Glioblastoma Multiforme

Nobendu Mukerjee et al. Metab Brain Dis. 2023 Jan.

Abstract

Glioblastoma (GB) are aggressive tumors that obstruct normal brain function. While the skull cannot expand in response to cancer growth, the growing pressure in the brain is generally the first sign. It can produce more frequent headaches, unexplained nausea or vomiting, blurred peripheral vision, double vision, a loss of feeling or movement in an arm or leg, and difficulty speaking and concentrating; all depend on the tumor's location. GB can also cause vascular thrombi, damaging endothelial cells and leading to red blood cell leakage. Latest studies have revealed the role of single nucleotide polymorphisms (SNPs) in developing and spreading cancers such as GB and breast cancer. Many discovered SNPs are associated with GB, particularly in great abundance in the promoter region, creating polygenetic vulnerability to glioma. This study aims to compile a list of some of the most frequent and significant SNPs implicated with GB formation and proliferation.

Keywords: Epidermal growth factors receptor; Glioblastoma; Single nucleotide polymorphisms; Tumors.

PubMed Disclaimer

References

    1. Abels ER, Breakefield XO (2016) Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol 36(3):301–312 - DOI
    1. Boland E, Clayton-Smith J, Woo VG, McKee S, Manson FD, Medne L, Zackai E, Swanson EA, Fitzpatrick D, Millen KJ, Sherr EH (2007) Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum. Am J Hum Genet 81(2):292–303 - DOI
    1. Brenner AV, Butler MA, Wang SS, Ruder AM, Rothman N, Schulte PA, Chanock SJ, Fine HA, Linet MS, Inskip PD (2007) Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 28(12):2543–2547 - DOI
    1. Carrillo JA, Munoz CA (2012) Alternative chemotherapeutic agents: nitrosoureas, cisplatin, Irinotecan. Neurosurg Clin N Am 23(2):297–306 - DOI
    1. Chang JS, Yeh RF, Wiencke JK, Wiemels JL, Smirnov I, Pico AR, Tihan T, Patoka J, Miike R, Sison JD, Rice T (2008) Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests. Cancer Epidemiol Prevent Biomark 17(6):1368–1373 - DOI

Publication types

LinkOut - more resources